This population-based cohort study examines the agreement between medical records and patient report in assessing comorbidities.
This study evaluates self-reporting of symptomatic adverse events associated with treatment of cancer in patients participating in clinical trials.
Using data from a prostate cancer registry, this study correlated HSD3B1 genotype with response to androgen-deprivation therapy in patients with prostate cancer.
This Viewpoint describes the disproportionate domestic impact on rural and inner-city citizens of the United States caused by the recent immigration and travel ban, and seeks to affirm physicians’ commitment to more and not less diversity and inclusion.
This review looks at scalp cooling, an intervention that can prevent or reduce the severity of chemotherapy-induced alopecia.
This Viewpoint examines the need for physicians to approach end-of-life conversations with patients with terminal cancer prognoses with flexibility and an understanding of patient desires and needs.
This follow-up of a randomized clinical trial evaluates long-term survival in patients with gastrointestinal stromal tumors who were treated with 1 of 2 dose levels of imatinib mesylate and presents new molecular data regarding treatment outcomes.
This secondary analysis of a National Cancer Institute of Canada trial investigates quality of life at days 10 and 42 after radiotherapy with a bone metastases–specific quality-of-life tool.
This commentary discusses the findings of a randomized clinical trial of trastuzumab vs a biosimilar in patients with metastatic breast cancer that was published in JAMA and posits 3 questions for consideration moving forward in the development and clinical use of biosimilars.
A woman with metastatic melanoma receiving ipilimumab and nivolumab developed headaches during the course of her treatment and reported low energy levels and difficulty reading. What is your diagnosis?
This Viepoint examines the implementation and possible benefits of human-machine collaboration in treating patients with cancer.
This population-based, case-control, cohort study uses data from the Breast Cancer Surveillance Consortium to assess risk factors associated with breast cancer in premenopausal and postmenopausal women.
This cohort study investigates temporal patterns and factors associated with the receipt of adjuvant endocrine therapy in women with breast cancer in the National Cancer Database.
This case-control study assesses the association of cytotoxic, anti-inflammatory, and immunomodulating agents with the risk for developing myeloid neoplasms among patients with autoimmune disease.
This study examines whether low-dose computed tomography screening for lung cancer increased following the United States Preventive Services Task Force recommendations.